Outlook Therapeutics
OTLK
OTLK
61 hedge funds and large institutions have $8.59M invested in Outlook Therapeutics in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 23 increasing their positions, 11 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
26% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 19
81% less capital invested
Capital invested by funds: $44.7M → $8.59M (-$36.2M)
Holders
61
Holding in Top 10
–
Calls
$3.61M
Puts
$4K
Top Buyers
| 1 | +$528K | |
| 2 | +$341K | |
| 3 | +$331K | |
| 4 |
Renaissance Technologies
New York
|
+$246K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$190K |
Top Sellers
| 1 | -$6.9M | |
| 2 | -$2.89M | |
| 3 | -$2.6M | |
| 4 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$2.4M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$2.21M |